#  @BiotechTV BiotechTV BiotechTV posts on X about ceo, in the, ai, $bbio the most. They currently have [------] followers and [---] posts still getting attention that total [------] engagements in the last [--] hours. ### Engagements: [------] [#](/creator/twitter::1655096847793377284/interactions)  - [--] Week [------] +334% - [--] Month [-------] -37% - [--] Months [---------] +87% - [--] Year [---------] +21% ### Mentions: [--] [#](/creator/twitter::1655096847793377284/posts_active)  - [--] Week [--] -10% - [--] Month [---] +33% - [--] Months [---] +80% - [--] Year [---] +106% ### Followers: [------] [#](/creator/twitter::1655096847793377284/followers)  - [--] Week [------] +0.38% - [--] Month [------] +2.70% - [--] Months [------] +19% - [--] Year [------] +40% ### CreatorRank: [-------] [#](/creator/twitter::1655096847793377284/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) 54.81% [finance](/list/finance) 23.08% [travel destinations](/list/travel-destinations) 2.88% [cryptocurrencies](/list/cryptocurrencies) 2.88% [exchanges](/list/exchanges) 1.92% [technology brands](/list/technology-brands) 0.96% [countries](/list/countries) 0.96% **Social topic influence** [ceo](/topic/ceo) #2446, [in the](/topic/in-the) 8.65%, [ai](/topic/ai) 4.81%, [$bbio](/topic/$bbio) #50, [science](/topic/science) 3.85%, [update](/topic/update) 3.85%, [$upb](/topic/$upb) #12, [$crvs](/topic/$crvs) #1, [$legn](/topic/$legn) #29, [legn](/topic/legn) #29 **Top accounts mentioned or mentioned by** [@beonemedicines](/creator/undefined) [@johnvoyler](/creator/undefined) [@martintrevor](/creator/undefined) [@bradloncar](/creator/undefined) [@yaireinhorn](/creator/undefined) [@upstreambio](/creator/undefined) [@insmed](/creator/undefined) [@massbio](/creator/undefined) [@kendalleoc](/creator/undefined) [@ternspharma](/creator/undefined) [@nyse](/creator/undefined) [@soowannaway](/creator/undefined) [@legendbiotech](/creator/undefined) [@arcellx](/creator/undefined) [@stifel](/creator/undefined) [@stifelinst](/creator/undefined) [@nellomainolfi](/creator/undefined) [@ovidrxs](/creator/undefined) [@mammothbioscis](/creator/undefined) [@financebully](/creator/undefined) **Top assets mentioned** [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Upstream Bio, Inc. (UPB)](/topic/$upb) [Legend Biotech Corp (LEGN)](/topic/$legn) [Biogen Inc (BIIB)](/topic/$biib) [Arcellx, Inc. (ACLX)](/topic/$aclx) [Aardvark Therapeutics, Inc (AARD)](/topic/$aard) [One Cash (ONC)](/topic/$onc) [Insmed, Inc. (INSM)](/topic/$insm) [Terns Pharmaceuticals, Inc. (TERN)](/topic/$tern) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Arcus Biosciences, Inc. (RCUS)](/topic/$rcus) [Vaxcyte, Inc. (PCVX)](/topic/$pcvx) [Kymera Therapeutics, Inc. (KYMR)](/topic/$kymr) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Nanobiotix S.A. (NBTX)](/topic/$nbtx) [Sagimet Biosciences Inc. (SGMT)](/topic/$sgmt) [Genenta Science S.p.A. (GNTA)](/topic/$gnta) [Prime Medicine, Inc. (PRME)](/topic/$prme) [IO Biotech, Inc. (IOBT)](/topic/$iobt) [Lyell Immunopharma, Inc. (LYEL)](/topic/$lyel) [Nurix Therapeutics, Inc. (NRIX)](/topic/$nrix) [Rapport Therapeutics, Inc. (RAPP)](/topic/$rapp) [Bausch & Lomb Corp (BLCO)](/topic/$blco) [Recursion Pharmaceuticals, Inc. (RXRX)](/topic/$rxrx) [Neurocrine Biosciences, Inc. (NBIX)](/topic/$nbix) [Alumis Inc. (ALMS)](/topic/$alms) [Sana Biotechnology, Inc. (SANA)](/topic/$sana) [Vera Therapeutics, Inc. (VERA)](/topic/$vera) [ArriVent BioPharma, Inc. (AVBP)](/topic/$avbp) [Oruka Therapeutics, Inc. Common Stock (ORKA)](/topic/$orka) [Jade Biosciences, Inc. (JBIO)](/topic/$jbio) [IDEAYA Biosciences, Inc. Common Stock (IDYA)](/topic/$idya) [Ocular Therapeutix, Inc. (OCUL)](/topic/$ocul) [Kyverna Therapeutics, Inc. (KYTX)](/topic/$kytx) [Cullinan Management, Inc. (CGEM)](/topic/$cgem) [Instil Bio, Inc. (TIL)](/topic/$til) [Abivax SA (ABVX)](/topic/$abvx) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Xenon Pharmaceuticals Inc (XENE)](/topic/$xene) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [LB Pharmaceuticals Inc. (LBRX)](/topic/$lbrx) [BEAM (BEAM)](/topic/$beam) [Beam Therapeutics, Inc. (BEAM)](/topic/beam-therapeutics) [Soleno Therapeutics, Inc. Common Stock (SLNO)](/topic/$slno) [Annovis Bio Inc. (ANVS)](/topic/$anvs) [Disc Medicine, Inc. Common Stock (IRON)](/topic/$iron) ### Top Social Posts Top posts by engagements in the last [--] hours ": @Alnylam CEO Yvonne Greenstreet discusses the launch of Amvuttra in ATTR-CM and the company's new [----] ambitions. $ALNY Full video: https://www.biotechtv.com/post/alnylam-pharmaceuticals-january-13-2025 https://www.biotechtv.com/post/alnylam-pharmaceuticals-january-13-2025" [X Link](https://x.com/BiotechTV/status/2011222350646428028) 2026-01-13T23:42Z 10.7K followers, [----] engagements ": @Nanobiotix has a new platform that is meant to help RNA/DNA-based therapies gene therapies oncolytic viruses and other liver-delivered medicines have better efficacy. $NBTX Full video: https://www.biotechtv.com/post/nanobiotix-jefferies-london-november-18-2025 https://www.biotechtv.com/post/nanobiotix-jefferies-london-november-18-2025" [X Link](https://x.com/BiotechTV/status/1990866753887347134) 2025-11-18T19:36Z 10.7K followers, [----] engagements ": Later tonight from Boston we will be visiting @UpstreamBio to discuss today's asthma data. Let us know any questions you'd like asked. $UPB" [X Link](https://x.com/BiotechTV/status/2021608163179467169) 2026-02-11T15:32Z 10.7K followers, [----] engagements ": @sagimet presented a subset analysis of the FASCINATE-2 P2 trial of denifanstat suggesting improved fibrosis in MASH. #TLM24 $SGMT Full video: https://www.biotechtv.com/post/sagimet-biosciences-november-19-2024 https://www.biotechtv.com/post/sagimet-biosciences-november-19-2024" [X Link](https://x.com/BiotechTV/status/1858540560145096976) 2024-11-18T15:59Z 10.6K followers, [----] engagements ": Milan based @GenentaScience recently raised [--] million from a government investment fund as it takes its cell therapy into the clinic in renal cell carcinoma. $GNTA Full video: https://www.biotechtv.com/post/genenta-science-may-6-2025 https://www.biotechtv.com/post/genenta-science-may-6-2025" [X Link](https://x.com/BiotechTV/status/1919776861678170605) 2025-05-06T15:30Z 10.7K followers, [----] engagements ": @PrimeMedicine's new CEO Allan Reine walks us through the prime editing company's new focused pipeline. $PRME Full video: https://www.biotechtv.com/post/prime-medicine-july-17-2025 https://www.biotechtv.com/post/prime-medicine-july-17-2025" [X Link](https://x.com/BiotechTV/status/1945911638625853830) 2025-07-17T18:21Z 10.7K followers, 37.2K engagements ": @IOBiotech CEO Mai-Britt Zocca discusses the phase [--] pivotal trial result of the cancer vaccine Cylembio in first line advanced melanoma - and the company's strategy ahead. $IOBT Full video: https://www.biotechtv.com/post/io-biotech-august-15-2025 https://www.biotechtv.com/post/io-biotech-august-15-2025" [X Link](https://x.com/BiotechTV/status/1956389728414060874) 2025-08-15T16:17Z 10.7K followers, 13.2K engagements ": @MenloVentures published a report showing that the healthcare industry is the leading adopter of AI - @derekgxiao one of the co-authors shares key takeaways. Full video: https://www.biotechtv.com/post/menlo-ventures-ai-healthcare-derek-xiao https://www.biotechtv.com/post/menlo-ventures-ai-healthcare-derek-xiao" [X Link](https://x.com/BiotechTV/status/1986071002758217992) 2025-11-05T14:00Z 10.7K followers, [----] engagements ": @BeOneMedicines announced a phase [--] success for its HER2 bispecific today in gastric cancer. @johnvoyler walks us through that and the whole pipeline. $ONC Full video: https://www.biotechtv.com/post/beone-medicines-jefferies-london-november-17-2025 https://www.biotechtv.com/post/beone-medicines-jefferies-london-november-17-2025" [X Link](https://x.com/BiotechTV/status/1990467914491675010) 2025-11-17T17:11Z 10.7K followers, [----] engagements ": Lyell Immunopharma CEO Lynn Seely discusses her company's CD19/CD20 dual antigen CAR-T data at ASH. $LYEL Full video: https://www.biotechtv.com/post/lyell-immunopharma-ash-2025 https://www.biotechtv.com/post/lyell-immunopharma-ash-2025" [X Link](https://x.com/BiotechTV/status/1997823301864034425) 2025-12-08T00:19Z 10.7K followers, [----] engagements ": @Nurix_Tx CEO Arthur Sands discusses his company's BTK degrader data at ASH and highlights the benefits of degraders more broadly in oncology and I&I. $NRIX Full video: https://www.biotechtv.com/post/nurix-therapeutics-ash-2025 https://www.biotechtv.com/post/nurix-therapeutics-ash-2025" [X Link](https://x.com/BiotechTV/status/1998150836371742815) 2025-12-08T22:00Z 10.7K followers, [----] engagements ": Rapport Therapeutics has derived what it believes is 'unprecedented' early efficacy for its precision neuroscience treatment in focal onset seizures - its confidence comes from a unique trial design. $RAPP Full video: https://www.biotechtv.com/post/rapport-therapeutics-december-10-2025 https://www.biotechtv.com/post/rapport-therapeutics-december-10-2025" [X Link](https://x.com/BiotechTV/status/1998831576839516499) 2025-12-10T19:05Z 10.7K followers, [----] engagements ": @PolarisVC's Amy Schulman describes how her career in law led to running businesses for Pfizer and ultimately joining the VC world. She shares leanings from the last [--] years of biotech investing. Full video: https://www.biotechtv.com/post/bioventure-voices-polaris-partners-amy-schulman https://www.biotechtv.com/post/bioventure-voices-polaris-partners-amy-schulman" [X Link](https://x.com/BiotechTV/status/2005624851264905319) 2025-12-29T13:00Z 10.7K followers, [----] engagements ": Meeting spaces around Union Square are so expensive during JPM that one venture capital firm decided to host its meetings this week on a van roving around town. Say hello to THE HATTEBUS" [X Link](https://x.com/BiotechTV/status/2010522456344109383) 2026-01-12T01:21Z 10.6K followers, 97.9K engagements ": @BauschLomb Chairman & CEO @brentlsaunders covers the company's pharmaceutical pipeline for the eye. $BLCO Full video: https://www.biotechtv.com/post/bausch-lomb-janaury-12-2025 https://www.biotechtv.com/post/bausch-lomb-janaury-12-2025" [X Link](https://x.com/BiotechTV/status/2010900246814151047) 2026-01-13T02:22Z 10.7K followers, [----] engagements ": @Bridgebio Founder and CEO Neil Kumar shares his take on the state of biotech. $BBIO" [X Link](https://x.com/BiotechTV/status/2011240687002620408) 2026-01-14T00:55Z 10.7K followers, [----] engagements ": @argenxglobal recently announced that Karen Massey will become CEO as Tim Van Hauwermeiren transitions to Non-Executive Chairman in May. They both reflect on past success and the road ahead. $ARGX" [X Link](https://x.com/BiotechTV/status/2011265322771496970) 2026-01-14T02:33Z 10.7K followers, [----] engagements ": @BridgeBioPharma Founder & CEO Neil Kumar comments on the launch of Attruby and the company's next-generation efforts in this space. $BBIO" [X Link](https://x.com/BiotechTV/status/2011436555408490578) 2026-01-14T13:53Z 10.7K followers, [----] engagements ": @Insmed today has a $35B market cap but it wasn't always like that. CEO Will Lewis shares advice for entrepreneurs about making it through the ups and downs of biotech. $INSM" [X Link](https://x.com/BiotechTV/status/2011482899443290331) 2026-01-14T16:57Z 10.7K followers, [----] engagements ": @Insmed CEO Will Lewis discusses the launch BRINSUPRI and pipeline readouts ahead in [----]. $INSM. Full video: https://www.biotechtv.com/post/insmed-january-14-2026 https://www.biotechtv.com/post/insmed-january-14-2026" [X Link](https://x.com/BiotechTV/status/2011503177829663123) 2026-01-14T18:18Z 10.6K followers, [----] engagements ": @RecursionPharma's new CEO Najat Khan shares her vision for the company and for AI in biotech. $RXRX Full video: https://www.biotechtv.com/post/recursion-january-14-2026 https://www.biotechtv.com/post/recursion-january-14-2026" [X Link](https://x.com/BiotechTV/status/2011690274133852496) 2026-01-15T06:41Z 10.6K followers, [----] engagements ": @neurocrine's CEO Kyle Gano describes how the company's novel muscarinic agonist portfolio is rooted in novel drug design with its lead M4 agonist in late-stage trials. $NBIX Full video: https://www.biotechtv.com/post/neurocrine-biosciences-january-15-2026 https://www.biotechtv.com/post/neurocrine-biosciences-january-15-2026" [X Link](https://x.com/BiotechTV/status/2011825961965404189) 2026-01-15T15:41Z 10.7K followers, [----] engagements ": @_Alumis' CEO Martin Babler walks us through the two successful phase [--] trials the company announced for its TYK2 last week. $ALMS Full video: https://www.biotechtv.com/post/alumis-january-15-2026 https://www.biotechtv.com/post/alumis-january-15-2026" [X Link](https://x.com/BiotechTV/status/2011942026019733517) 2026-01-15T23:22Z 10.7K followers, [----] engagements ": Sana Bio's CEO Steve Harr describes the science behind the company's cell therapy program that aims to be a cure for type [--] diabetes. $SANA Full video: https://www.biotechtv.com/post/sana-biotechnology-january-15-2026 https://www.biotechtv.com/post/sana-biotechnology-january-15-2026" [X Link](https://x.com/BiotechTV/status/2011963066637038030) 2026-01-16T00:45Z 10.7K followers, 19.7K engagements ": This was a big week for the emerging protein degrader class of medicines with multiple companies presenting BTK data at ASH and Kymera announcing STAT6 data in atopic dermatitis. One of the leading CEOs in the field explains the promise" [X Link](https://x.com/BiotechTV/status/1999558496811958759) 2025-12-12T19:14Z 10.7K followers, [----] engagements ": @Official_VeraTx announced this week that the FDA accepted the companys filing for atacicept a potential new treatment for IgA Nephropathy. $VERA Full video: https://www.biotechtv.com/post/vera-therapeutics-january-11-2026 https://www.biotechtv.com/post/vera-therapeutics-january-11-2026" [X Link](https://x.com/BiotechTV/status/2010557460369777110) 2026-01-12T03:40Z 10.7K followers, [----] engagements ": Clear Street Senior Biotech Analyst Kaveri Pohlman shares her take on biotech for [----] and discusses her top picks. $AVBP $ORKA $JBIO $ZURA $PVLA Full video: https://www.biotechtv.com/post/kaveri-pohlman-january-22-2026 https://www.biotechtv.com/post/kaveri-pohlman-january-22-2026" [X Link](https://x.com/BiotechTV/status/2014375842814611685) 2026-01-22T16:33Z 10.7K followers, [----] engagements ": Tune in to BiotechTV as @MassBio President & CEO @KendalleOC hosts a discussion with Leslie Williams and Ed Kaye about leadership and the biotech ecosystem" [X Link](https://x.com/BiotechTV/status/2022001328130793836) 2026-02-12T17:34Z 10.7K followers, [----] engagements ": "A special drug like this does not come around every day." @TernsPharma CEO Amy Burroughs previews the company's upcoming ASH presentation for tern-701 in relapsed/refractory cml. $TERN Full video: https://www.biotechtv.com/post/terns-pharmaceuticals-november-19-2025 https://www.biotechtv.com/post/terns-pharmaceuticals-november-19-2025" [X Link](https://x.com/BiotechTV/status/1991209726500122941) 2025-11-19T18:19Z 10.7K followers, [----] engagements ": @NYSE Market Strategist @Eric_Criscuolo discusses how the newly appointed Federal Reserve Chair and other market factors might affect the biotech sector. Full video: https://www.biotechtv.com/post/nyse-eric-criscuolo-february-2-2026 https://www.biotechtv.com/post/nyse-eric-criscuolo-february-2-2026" [X Link](https://x.com/anyuser/status/2018455085840237009) 2026-02-02T22:42Z 10.7K followers, [----] engagements ": @generalatlantic's Brett Zbar describes investing through the lens of private equity and touches on key technology themes that interest him. Full video: https://www.biotechtv.com/post/bioventure-voices-brett-zbar-february-9-2026 https://www.biotechtv.com/post/bioventure-voices-brett-zbar-february-9-2026" [X Link](https://x.com/BiotechTV/status/2020837587196235916) 2026-02-09T12:30Z 10.7K followers, 13K engagements ": @UpstreamBio's CEO Rand Sutherland discusses today's severe asthma data for verekitug a TSLP receptor antagonist. $UPB Full video: https://www.biotechtv.com/post/upstream-bio-february-11-2026 https://www.biotechtv.com/post/upstream-bio-february-11-2026" [X Link](https://x.com/BiotechTV/status/2021730468102631543) 2026-02-11T23:38Z 10.7K followers, [----] engagements ": Mizuho Senior Biotech Analyst @soowannaway shares his take on three key biotech trials that are scheduled to read out soon and one that recently happened. $IDYA $EYPT $OCUL $PVLA $CRVS Full video: https://www.biotechtv.com/post/graig-suvannavejh-february-12-2026 https://www.biotechtv.com/post/graig-suvannavejh-february-12-2026" [X Link](https://x.com/BiotechTV/status/2022093018862645627) 2026-02-12T23:38Z 10.7K followers, 23.2K engagements ": Checking in on the progress of CAR-T for autoimmune conditions with the CEO of @Kyverna_Tx - the company's first (and first for the field) registration intended trial will read in the first half of [----]. $KYTX Full video: https://www.biotechtv.com/post/kyverna-therapeutics-august-13-2025 https://www.biotechtv.com/post/kyverna-therapeutics-august-13-2025" [X Link](https://x.com/BiotechTV/status/1955780387369836627) 2025-08-13T23:55Z 10.7K followers, [----] engagements ": @CullinanTx's CEO Nadim Ahmed highlights the company's FLT3xCD3 bispecific T-cell engager data at ASH in AML and MDS. $CGEM Full video: https://www.biotechtv.com/post/cullinan-therapeutics-ash-2025 https://www.biotechtv.com/post/cullinan-therapeutics-ash-2025" [X Link](https://x.com/BiotechTV/status/1998119378819113268) 2025-12-08T19:55Z 10.7K followers, [----] engagements ": Aaron Morris CEO of @PostEra_AI discusses the companys collaborations with Pfizer and Amgen and how AI can improve drug development in womens health" [X Link](https://x.com/BiotechTV/status/2011319956223508879) 2026-01-14T06:10Z 10.7K followers, [----] engagements ": @astellas' CEO Naoki Okamura describes the type of assets the company looks for externally and covers key internal pipeline assets. Full video: https://www.biotechtv.com/post/astellas-pharma-january-14-2026 https://www.biotechtv.com/post/astellas-pharma-january-14-2026" [X Link](https://x.com/BiotechTV/status/2011625929022587302) 2026-01-15T02:26Z 10.7K followers, [----] engagements ": Perceptive Advisors' Joe Edelman one of the top investors in biotech shares his investment philosophy. See the whole interview here: https://www.biotechtv.com/post/joseph-edelman-perceptive-advisors-january-15-2026 https://www.biotechtv.com/post/joseph-edelman-perceptive-advisors-january-15-2026" [X Link](https://x.com/BiotechTV/status/2012597100006023344) 2026-01-17T18:45Z 10.7K followers, 16.4K engagements ": @InstilBio CEO Bronson Crouch discusses the company's PD1 x VEGF and shares a quick take on this morning's competitor news. #ASCO25 $TIL Full video: https://www.biotechtv.com/post/instil-bio-asco-2025 https://www.biotechtv.com/post/instil-bio-asco-2025" [X Link](https://x.com/BiotechTV/status/1928559714318553422) 2025-05-30T21:10Z 10.7K followers, [----] engagements "- : @Abivax_ CEO Marc de Garidel discusses physician and payor feedback after obefazimod's phase [--] UC induction readouts and next steps regarding maintenance and Crohn's. #BIOEurope $ABVX Full video: https://www.biotechtv.com/post/bio-europe-2025-abivax https://www.biotechtv.com/post/bio-europe-2025-abivax" [X Link](https://x.com/BiotechTV/status/1985291664877854927) 2025-11-03T10:23Z 10.7K followers, 51.6K engagements ": Legend Biotech CEO Ying Huang shares a post-earnings update from the company's new R&D Center in Philadelphia. $LEGN Full video: https://www.biotechtv.com/post/legend-biotech-november-13-2025 https://www.biotechtv.com/post/legend-biotech-november-13-2025" [X Link](https://x.com/BiotechTV/status/1989080422920384671) 2025-11-13T21:18Z 10.7K followers, [----] engagements ": During an event at Legend Biotech's new R&D Center in Philadelphia today a CAR-T recipient had some words for the biotech industry" [X Link](https://x.com/BiotechTV/status/1989103139056922891) 2025-11-13T22:48Z 10.7K followers, [----] engagements ": @LegendBiotech CEO Ying Huang discusses new long-term Carvykti data looming competition a CD19+CD20 program and in vivo CAR-T. $LEGN Full video: https://www.biotechtv.com/post/legend-biotech-ash-2025 https://www.biotechtv.com/post/legend-biotech-ash-2025" [X Link](https://x.com/BiotechTV/status/1997391778329116672) 2025-12-06T19:44Z 10.7K followers, [----] engagements ": We will check in with Mizuho senior analyst Salim Syed on some of the key names he covers. $BBIO $CYTK $PCVX $BIIB $RCUS and more" [X Link](https://x.com/BiotechTV/status/2008873384562901493) 2026-01-07T12:08Z 10.7K followers, [----] engagements ": @Mizuho Senior Biotech Analyst Salim Syed highlights key companies in the news he covers heading into the new year. $BBIO $CYTK $PCVX $BIIB $RCUS Full video: https://www.biotechtv.com/post/mizuho-salim-syed-january-7-2026 https://www.biotechtv.com/post/mizuho-salim-syed-january-7-2026" [X Link](https://x.com/BiotechTV/status/2008959467908682200) 2026-01-07T17:50Z 10.7K followers, 12.1K engagements ": Baird Senior Analyst @BrianSkorney comments on Monday's conference news and highlights his top picks ahead for [----]. $BHVN $XENE $BIIB $SRPT Full video: https://www.biotechtv.com/post/brian-skorney-january-12-2025 https://www.biotechtv.com/post/brian-skorney-january-12-2025" [X Link](https://x.com/BiotechTV/status/2010762513391194303) 2026-01-12T17:15Z 10.7K followers, [----] engagements ": CEO Heather Turner tells us about the neuropsychiatric diseases medicine that enabled @lb_pharma to IPO in a tough market last year. $LBRX Full video: https://www.biotechtv.com/post/lb-pharmaceuticals-january-15-2026 https://www.biotechtv.com/post/lb-pharmaceuticals-january-15-2026" [X Link](https://x.com/BiotechTV/status/2011921269130920154) 2026-01-15T21:59Z 10.7K followers, [----] engagements ": @arcellx CEO Rami Elghandour discusses the results presented today of the iMMagine-1 Study for the company's BCMA CAR-T. #EHA2025 $ACLX Full video: https://www.biotechtv.com/post/arcellx-eha-2025 https://www.biotechtv.com/post/arcellx-eha-2025" [X Link](https://x.com/BiotechTV/status/1933974834691600385) 2025-06-14T19:48Z 10.7K followers, [----] engagements ": @UpstreamBio is focused on the TSLP space and has a unique approach of targeting the receptor as opposed to the ligand. It might give them a better dosing and efficacy profile. $UPB @Stifel @StifelInst Full video: https://www.biotechtv.com/post/upstream-bio-stifel-november-11-2025 https://www.biotechtv.com/post/upstream-bio-stifel-november-11-2025" [X Link](https://x.com/BiotechTV/status/1988262703740117173) 2025-11-11T15:09Z 10.7K followers, [----] engagements ": @KymeraTx's Founder & CEO @NelloMainolfi recaps Monday's STAT6 data and discusses the next steps in development. $KYMR Full video: https://www.biotechtv.com/post/kymera-therapeutics-december-10-2025 https://www.biotechtv.com/post/kymera-therapeutics-december-10-2025" [X Link](https://x.com/BiotechTV/status/1998899335673819473) 2025-12-10T23:35Z 10.7K followers, [----] engagements ": @BeamTx's CEO @john_evans3 shares an update on based editing for alpha-1 antitrypsin deficiency sickle cell disease and more. $BEAM Full video: https://www.biotechtv.com/post/beam-therapeutics-january-12-2026 https://www.biotechtv.com/post/beam-therapeutics-january-12-2026" [X Link](https://x.com/BiotechTV/status/2010833587889979726) 2026-01-12T21:57Z 10.7K followers, [----] engagements ": @SolenoTx Chairman & CEO Anish Bhatnager discusses the launch of its Prader-Willi syndrome therapy VYKAT XR. $SLNO Full video: https://www.biotechtv.com/post/soleno-therapeutics-january-14-2026 https://www.biotechtv.com/post/soleno-therapeutics-january-14-2026" [X Link](https://x.com/BiotechTV/status/2011559747548561809) 2026-01-14T22:03Z 10.7K followers, [----] engagements ": Co-Founders Sheila Gujrathi and Julia Owens talk about the creation of the Biotech CEO Sisterhood and the new dimensions and next steps it is taking as an organization ahead. Full video: https://www.biotechtv.com/post/biotech-ceo-sisterhood-panel-jpm26 https://www.biotechtv.com/post/biotech-ceo-sisterhood-panel-jpm26" [X Link](https://x.com/anyuser/status/2018313913347998059) 2026-02-02T13:21Z 10.7K followers, [----] engagements ": Today we are in New York at the home of our sponsor the @NYSE for its annual partnership day. If you are a biotech company looking to list this year (or beyond) please reach out to Johanna Grossman" [X Link](https://x.com/anyuser/status/2018424800058708144) 2026-02-02T20:42Z 10.7K followers, [----] engagements ": @OvidRx's new CEO Meg Alexander walks us through the company's lead programs in neurology. $OVID Full video: https://www.biotechtv.com/post/ovid-therapeutics-february2-2025 https://www.biotechtv.com/post/ovid-therapeutics-february2-2025" [X Link](https://x.com/anyuser/status/2018443689895591990) 2026-02-02T21:57Z 10.7K followers, [----] engagements ": @mammothbiosci Co-Founder & CEO @martintrevor_ shares advice for scientists thinking about building a biotech company" [X Link](https://x.com/BiotechTV/status/2018458394685051331) 2026-02-02T22:55Z 10.7K followers, [----] engagements ": @AnnovisBio's Founder & CEO Maria Maccecchini shares an update on the oral small molecule buntanetap which is currently in a pivotal trial for Alzheimer's. $ANVS Full video: https://www.biotechtv.com/post/annovis-bio-february-2-2026 https://www.biotechtv.com/post/annovis-bio-february-2-2026" [X Link](https://x.com/anyuser/status/2018474356536697325) 2026-02-02T23:59Z 10.7K followers, [----] engagements ": @mammothbioscis Co-Founder & CEO @martintrevor_ talks about the learning curve he experienced when making the jump from academia to industry" [X Link](https://x.com/BiotechTV/status/2018787454879474050) 2026-02-03T20:43Z 10.7K followers, [----] engagements ": In recent years biotech has seen a surge of success in the neuroscience field. @OvidRx's CEO Meg Alexander describes what she believes is behind it" [X Link](https://x.com/BiotechTV/status/2018800366243192904) 2026-02-03T21:34Z 10.7K followers, [----] engagements ": @mammothbioscis Co-Founder & CEO @martintrevor_ describes how the company looks beyond Cas9 as it uses CRISPR to develop new therapies" [X Link](https://x.com/BiotechTV/status/2019102853214990731) 2026-02-04T17:36Z 10.7K followers, [----] engagements ": @GatcHealth has created an AI platform to predict clinical trial outcomes - it is already being used for things from insuring clinical trials to helping with pipeline optimization Full video: https://www.biotechtv.com/post/gatc-health-february-4-2026 https://www.biotechtv.com/post/gatc-health-february-4-2026" [X Link](https://x.com/anyuser/status/2019177091028365736) 2026-02-04T22:31Z 10.7K followers, [----] engagements ": Could the time of day that cancer immunotherapy treatments are administered affect their effectiveness An intriguing @NatureMedicine paper suggests that the answer could be yes. Link to research: https://www.nature.com/articles/s41591-025-04181-w https://www.nature.com/articles/s41591-025-04181-w" [X Link](https://x.com/BiotechTV/status/2020942263535403237) 2026-02-09T19:25Z 10.7K followers, [----] engagements ": With #SLAS2026 in Boston right now the use of machine learning with robotics and automated lab equipment is on full display. One company in the space @AtinaryTech showed us their "Self-Driving Lab" setup in the Seaport. Full video: https://www.biotechtv.com/post/atinary-self-driving-lab-slas-2026 https://www.biotechtv.com/post/atinary-self-driving-lab-slas-2026" [X Link](https://x.com/BiotechTV/status/2021303191501963514) 2026-02-10T19:20Z 10.7K followers, [----] engagements ": "We are able to generate as many data an knowledge in a week as what a student can produce throughout their PhD." @AtinaryTech's CTO Loc Roch describes how a combination of machine learning and robotics is changing how science is done" [X Link](https://x.com/anyuser/status/2021314940095574176) 2026-02-10T20:06Z 10.7K followers, [----] engagements ": Mizuho Senior Biotech Analyst @soowannaway gave his take on the recent $CRVS ITK data today. Plus discussing three other trials scheduled to read out imminently. See the full episode: https://www.biotechtv.com/post/graig-suvannavejh-february-12-2026 https://www.biotechtv.com/post/graig-suvannavejh-february-12-2026" [X Link](https://x.com/BiotechTV/status/2022114963477987715) 2026-02-13T01:05Z 10.7K followers, [----] engagements ": @MassBio CEO @KendalleOC moderates a discussion with @AuroraTher CEO Ed Kaye and DaCapo Brainscience CEO @LeslieJWilliams about the future of biotech. Watch the full discussion: https://www.biotechtv.com/post/ceo-roundtable-kendalle-burlin-oconnell-ed-kaye-leslie-williams-february-13 https://www.biotechtv.com/post/ceo-roundtable-kendalle-burlin-oconnell-ed-kaye-leslie-williams-february-13" [X Link](https://x.com/BiotechTV/status/2022294689328623989) 2026-02-13T13:00Z 10.7K followers, [----] engagements ": @BeOneMedicines CEO @johnvoyler on the state of biotech modalities and SF vs London. $ONC" [X Link](https://x.com/BiotechTV/status/1990476890222874801) 2025-11-17T17:47Z 10.6K followers, [----] engagements ": Ipsen has done a string of deals over recent years including acquiring ImCheck last month. CEO David Loew says the company has billions in firepower to do more. Full video: https://www.biotechtv.com/post/ipsen-jefferies-london-november-19-2025 https://www.biotechtv.com/post/ipsen-jefferies-london-november-19-2025" [X Link](https://x.com/BiotechTV/status/1991231565611827311) 2025-11-19T19:46Z 10.6K followers, [----] engagements ": @DiscMedicine CEO John Quisel walks us through the RALLY-MF Phase [--] trial data of DISC-0974 in anemia of myelofibrosis. $IRON Full video: https://www.biotechtv.com/post/disc-medicine-ash-2025 https://www.biotechtv.com/post/disc-medicine-ash-2025" [X Link](https://x.com/BiotechTV/status/1997721529900314840) 2025-12-07T17:35Z 10.6K followers, [----] engagements ": @BluejayThera's CEO Keting Chu talks about what led to the the successful $620M+ acquisition of her company and its chronic hepatitis delta virus antibody by @mirumpharma. Full video: https://www.biotechtv.com/post/bluejay-therapeutics-january-14-2026 https://www.biotechtv.com/post/bluejay-therapeutics-january-14-2026" [X Link](https://x.com/BiotechTV/status/2012651824575062283) 2026-01-17T22:22Z 10.6K followers, [----] engagements ": @Nicole_Paulk describes how @SirenBio is using AAV gene therapy to treat cancer. Plus platform companies vs asset companies in biotech" [X Link](https://x.com/BiotechTV/status/2015922092483465511) 2026-01-26T22:57Z 10.7K followers, [----] engagements ": Corvus Pharma CEO Richard Miller fields follow-up questions about last week's atopic dermatitis data for the ITK inhibitor soquelitinib. $CRVS Full video: https://www.biotechtv.com/post/corvus-pharma-january-28-2026 https://www.biotechtv.com/post/corvus-pharma-january-28-2026" [X Link](https://x.com/BiotechTV/status/2016611479789654328) 2026-01-28T20:36Z 10.6K followers, 24.3K engagements ": Lexeo Therapeutics' CEO Nolan Townsend highlights recent FA cardiomyopathy data and the path ahead in that indication. Plus the latest on PKP2 ACM and more. $LXEO Full video: https://www.biotechtv.com/post/lexeo-therapeutics-april-23-2025 https://www.biotechtv.com/post/lexeo-therapeutics-april-23-2025" [X Link](https://x.com/BiotechTV/status/1915166053123961157) 2025-04-23T22:09Z 10.7K followers, 19.8K engagements ": @MazeInBiotech which had its IPO earlier this year is using insights from genetics to develop small molecules - its most advanced program is for a genetic kidney disease. $MAZE Full video: https://www.biotechtv.com/post/maze-therapeutics-august-11-2025 https://www.biotechtv.com/post/maze-therapeutics-august-11-2025" [X Link](https://x.com/BiotechTV/status/1955020511773352080) 2025-08-11T21:36Z 10.7K followers, [----] engagements "Company News: @LongboardP's CEO describes today's open label extension data for bexicaserin in Developmental and Epileptic Encephalopathies. $LBPH Full video: https://www.biotechtv.com/post/longboard-pharmaceuticals-june-10-2024 https://www.biotechtv.com/post/longboard-pharmaceuticals-june-10-2024" [X Link](https://x.com/BiotechTV/status/1800296550431617209) 2024-06-10T22:38Z 10.7K followers, 11K engagements ": @KitePharma's global head discusses the progress of the CAR-T field @arcellx's BCMA data cures in CD19 autoimmune and future targets. #ASH24 $GILD $ACLX Full video: https://www.biotechtv.com/post/kite-pharma-ash-2024 https://www.biotechtv.com/post/kite-pharma-ash-2024" [X Link](https://x.com/BiotechTV/status/1865995815585731044) 2024-12-09T05:44Z 10.7K followers, [----] engagements ": Rachel Haurwitz shares an update on @CaribouBio's allo CAR-T programs in NHL multiple myeloma and lupus. $CRBU Full video: https://www.biotechtv.com/post/caribou-biosciences-january-15-2025 https://www.biotechtv.com/post/caribou-biosciences-january-15-2025" [X Link](https://x.com/BiotechTV/status/1879651154310947232) 2025-01-15T22:05Z 10.7K followers, [----] engagements ": @KymeraTx Founder & CEO @NelloMainolfi discusses the safety degradation and biomarker profile he sees in the company's STAT6 healthy volunteer data. $KYMR Full video: https://www.biotechtv.com/post/kymera-therapeutics-june-4-2025 https://www.biotechtv.com/post/kymera-therapeutics-june-4-2025" [X Link](https://x.com/BiotechTV/status/1930371809423061233) 2025-06-04T21:11Z 10.7K followers, 10K engagements ": Checking in with the co-founders of @AmylyxPharma which now has one program in pivotal another that may start soon and earlier stage clinical programs that will have data this year. $AMLX Full video: https://www.biotechtv.com/post/amylyx-pharmaceuticals-june-25-2025 https://www.biotechtv.com/post/amylyx-pharmaceuticals-june-25-2025" [X Link](https://x.com/BiotechTV/status/1937997270273954087) 2025-06-25T22:12Z 10.7K followers, [----] engagements ": The CEO of @AltoNeuro which is working on precision medicine and enhanced patient selection for neuroscience talks about how the company is using AI and machine learning in its development programs. Full video: https://www.biotechtv.com/post/alto-neuroscience-july-22-2025 https://www.biotechtv.com/post/alto-neuroscience-july-22-2025" [X Link](https://x.com/BiotechTV/status/1947849100637896976) 2025-07-23T02:39Z 10.7K followers, [----] engagements ": Dropping by the @BeOneMedicines booth at ASH and visiting with @johnvoyler. Plus what does a CEO do at a conference like this" [X Link](https://x.com/BiotechTV/status/1997420633014108163) 2025-12-06T21:39Z 10.7K followers, [----] engagements "From Zurich: The Co-Founder & CEO of @MolecularPrtnrs describes their DARPin technology platform and how it is being put to use. $MOLN Full video: https://twitter.com/i/web/status/1838399067430207974 https://www.biotechtv.com/post/molecular-partners-september-24-2024 https://twitter.com/i/web/status/1838399067430207974 https://www.biotechtv.com/post/molecular-partners-september-24-2024" [X Link](https://x.com/BiotechTV/status/1838399067430207974) 2024-09-24T02:04Z 10.7K followers, [----] engagements ": @AstriaTx licensed its HAE treatment Navenibart to Kaken Pharmaceutical for the Japanese market. It is a kallikrein inhibitor that is in phase [--] and is dosed up to every six months. $ATXS Full video: https://www.biotechtv.com/post/astria-therapeutics-august-7-2025 https://www.biotechtv.com/post/astria-therapeutics-august-7-2025" [X Link](https://x.com/BiotechTV/status/1953537900907294759) 2025-08-07T19:25Z 10.7K followers, [----] engagements ": Zealand Pharma CEO Adam Steensberg (strongly) believes that amylins will overtake GLPs as the backbones of obesity treatments in the future. Full video: https://www.biotechtv.com/post/zealand-pharma-jefferies-london-november-18-2025 https://www.biotechtv.com/post/zealand-pharma-jefferies-london-november-18-2025" [X Link](https://x.com/BiotechTV/status/1990880148351070330) 2025-11-18T20:29Z 10.7K followers, 11.8K engagements "Company News: Spun out of Paragon Oruka Therapeutics raised $275M in a reverse merger today to tackle skin conditions in the I&I space. The company's CEO describes the science behind it. Full video: https://twitter.com/i/web/status/1775634322672017440 https://www.biotechtv.com/post/oruka-therapeutics-april-3-2024 https://twitter.com/i/web/status/1775634322672017440 https://www.biotechtv.com/post/oruka-therapeutics-april-3-2024" [X Link](https://x.com/BiotechTV/status/1775634322672017440) 2024-04-03T21:19Z 10.7K followers, [----] engagements "Company News: The CEO of @Context_Tx on raising $100M for a Claudin [--] x CD3 bispecific this month. $CNTX Full video: https://www.biotechtv.com/post/context-therapeutics-may-21-2024 https://www.biotechtv.com/post/context-therapeutics-may-21-2024" [X Link](https://x.com/BiotechTV/status/1792868286033539129) 2024-05-21T10:41Z 10.7K followers, [----] engagements "From Research Triangle NC: With key EHA data coming up Shattuck looks to build on its hypothesis that adding an immune agonism component will transform the SIRP space. $STTK Full video: https://twitter.com/i/web/status/1793961396515868871 https://www.biotechtv.com/post/shattuck-labs-may-24-2024 https://twitter.com/i/web/status/1793961396515868871 https://www.biotechtv.com/post/shattuck-labs-may-24-2024" [X Link](https://x.com/BiotechTV/status/1793961396515868871) 2024-05-24T11:05Z 10.7K followers, [----] engagements "Company News: Aardvark Therapeutics CEO Tien Lee on this month's $85M series C and leveraging TAS2R to modulate hunger and as a weight loss strategy. Full video: https://twitter.com/i/web/status/1795550451489702105 https://www.biotechtv.com/post/aardvark-therapeutics-may-28-2024 https://twitter.com/i/web/status/1795550451489702105 https://www.biotechtv.com/post/aardvark-therapeutics-may-28-2024" [X Link](https://x.com/BiotechTV/status/1795550451489702105) 2024-05-28T20:19Z 10.7K followers, [----] engagements "Behind the Science: Philadelphia-based @Passage_Bio is aiming to treat frontotemporal dementia by using an AAV gene therapy to boost progranulin levels in the brain. Full video: https://www.biotechtv.com/post/passage-bio-july-10-2024 https://www.biotechtv.com/post/passage-bio-july-10-2024" [X Link](https://x.com/BiotechTV/status/1811115842295451849) 2024-07-10T19:10Z 10.7K followers, [----] engagements "Company News: Praxis Precision Medicines a CNS focused company has key data events scheduled to read out over the remainder of the year. CEO Marcio Souza describes the programs. Full video: https://www.biotechtv.com/post/praxis-precision-medicines-august-14-2024 https://www.biotechtv.com/post/praxis-precision-medicines-august-14-2024" [X Link](https://x.com/BiotechTV/status/1823877437605732813) 2024-08-15T00:20Z 10.7K followers, [----] engagements "Company News: The CEO of @TarsusRx shares an update on the launch of XDEMVY and what the company is doing to reach more patients in the quarters ahead. $TARS Full video: https://www.biotechtv.com/post/tarsus-pharmaceuticals-september-3-2024 https://www.biotechtv.com/post/tarsus-pharmaceuticals-september-3-2024" [X Link](https://x.com/BiotechTV/status/1831024804582871228) 2024-09-03T17:41Z 10.7K followers, [----] engagements ": Many companies are trying to differentiate themselves in the obesity drug race by developing an oral GLP-1. But count Zealand Pharma's CEO skeptical of this approach. See our full deep dive on the obesity space with him here: https://www.biotechtv.com/post/zealand-pharma-october-10-2024 https://www.biotechtv.com/post/zealand-pharma-october-10-2024" [X Link](https://x.com/BiotechTV/status/1844716640081944979) 2024-10-11T12:28Z 10.7K followers, [----] engagements "' : Dr. Tien Lee Founder and CEO of Aardvark Therapeutics spoke with @nyse's @JudyKShaw about developing therapies that target bitter taste receptors to turn off hunger" [X Link](https://x.com/BiotechTV/status/1852051662741102974) 2024-10-31T18:15Z 10.7K followers, [----] engagements ": After announcing FIH data from its oral GLP in obesity in September @TernsPharma is also getting ready to release initial data in December for its allosteric BCR ABL cancer program. $TERN Full video: https://www.biotechtv.com/post/terns-pharmaceuticals-november-21-2024 https://www.biotechtv.com/post/terns-pharmaceuticals-november-21-2024" [X Link](https://x.com/BiotechTV/status/1859523640364052967) 2024-11-21T09:05Z 10.7K followers, [----] engagements ": @Vir_Biotech presented data from programs for chronic hepatitis B and chronic hepatitis delta at #TLM24. $VIR Full video: https://www.biotechtv.com/post/vir-biotechnology-november-22-2024 https://www.biotechtv.com/post/vir-biotechnology-november-22-2024" [X Link](https://x.com/BiotechTV/status/1859691666728419609) 2024-11-21T20:13Z 10.7K followers, [----] engagements ": @LegendBiotech's CEO Ying Huang discusses new CARVYKTI data at #ASCO25 as well as early stage data for emerging CAR-T targets against solid tumors. $LEGN Full video: https://www.biotechtv.com/post/legend-biotech-asco-2025 https://www.biotechtv.com/post/legend-biotech-asco-2025" [X Link](https://x.com/BiotechTV/status/1929333024186876329) 2025-06-02T00:23Z 10.7K followers, [----] engagements ": @BicaraTx's CEO Claire Mazumdar discusses the company's EGFR x TGF- data in head and neck cancer and compares and contrasts it with a closely watched competitor. #ASCO25 $BCAX Full video: https://www.biotechtv.com/post/bicara-therapeutics-asco-2025 https://www.biotechtv.com/post/bicara-therapeutics-asco-2025" [X Link](https://x.com/BiotechTV/status/1929347917778657770) 2025-06-02T01:22Z 10.7K followers, 19.9K engagements ": @CandelTx's CEO @paulpetertak describes phase [--] prostate cancer data from the company's off-the-shelf adeno delivered cancer immunotherapy. #ASCO25 $CADL Full video: https://www.biotechtv.com/post/candel-therapeutics-asco-2025 https://www.biotechtv.com/post/candel-therapeutics-asco-2025" [X Link](https://x.com/BiotechTV/status/1929688360614089196) 2025-06-02T23:55Z 10.7K followers, [----] engagements ": Ahead of a year of increased clinical activity @entradatx's CEO Dipal Doshi discusses the company's EEV platform DMD programs and a Vertex partnership in DM1. Full video: https://www.biotechtv.com/post/entrada-therapeutics-october-22-2025 https://www.biotechtv.com/post/entrada-therapeutics-october-22-2025" [X Link](https://x.com/BiotechTV/status/1981130335174713520) 2025-10-22T22:47Z 10.7K followers, [----] engagements ": Aardvark Therapeutics' approach to obesity is to inhibit hunger (vs appetite). It has a key pivotal trial reading in Prader-Willi syndrome next year and is also working on weight loss. $AARD @Stifel @StifelInst Full video: https://www.biotechtv.com/post/aardvark-therapeutics-stifel-november-11-2025 https://www.biotechtv.com/post/aardvark-therapeutics-stifel-november-11-2025" [X Link](https://x.com/BiotechTV/status/1988308813032886437) 2025-11-11T18:12Z 10.7K followers, [----] engagements ": BiotechTV attended the ribbon cutting ceremony of Legend Biotechs new R&D center in Philadelphia today which is in the new [----] Market life sciences building that was built by our sponsor @bt_prop. We caught up with Legend CEO Ying Huang there" [X Link](https://x.com/BiotechTV/status/1989066258663501860) 2025-11-13T20:22Z 10.7K followers, [----] engagements ": @AscentagePharma Chairman & CEO Dajun Yang shares an update on the company's Bcl-2 lisaftoclax which was recently approved in China and is in multiple global registration studies. $AAPG Full video: https://www.biotechtv.com/post/ascentage-pharma-ash-2025 https://www.biotechtv.com/post/ascentage-pharma-ash-2025" [X Link](https://x.com/BiotechTV/status/1998392194538057849) 2025-12-09T14:00Z 10.7K followers, [----] engagements ": Starting Sunday tune in to BiotechTV's coverage of biotech's biggest week of the year" [X Link](https://x.com/BiotechTV/status/2009706711691809108) 2026-01-09T19:19Z 10.7K followers, [----] engagements ": @arcellx CEO Rami Elghandour discusses a data update of the iMMagine-1 Study for the company's BCMA CAR-T. The data showed a 62% CR/sCR at a median follow-up of [---] months. #ASH24 $ACLX Full video: https://www.biotechtv.com/post/arcellx-ash-2024 https://www.biotechtv.com/post/arcellx-ash-2024" [X Link](https://x.com/BiotechTV/status/1865980458494026159) 2024-12-09T04:43Z 10.7K followers, [----] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@BiotechTV BiotechTVBiotechTV posts on X about ceo, in the, ai, $bbio the most. They currently have [------] followers and [---] posts still getting attention that total [------] engagements in the last [--] hours.
Social category influence stocks 54.81% finance 23.08% travel destinations 2.88% cryptocurrencies 2.88% exchanges 1.92% technology brands 0.96% countries 0.96%
Social topic influence ceo #2446, in the 8.65%, ai 4.81%, $bbio #50, science 3.85%, update 3.85%, $upb #12, $crvs #1, $legn #29, legn #29
Top accounts mentioned or mentioned by @beonemedicines @johnvoyler @martintrevor @bradloncar @yaireinhorn @upstreambio @insmed @massbio @kendalleoc @ternspharma @nyse @soowannaway @legendbiotech @arcellx @stifel @stifelinst @nellomainolfi @ovidrxs @mammothbioscis @financebully
Top assets mentioned BridgeBio Pharma, Inc. Common Stock (BBIO) Upstream Bio, Inc. (UPB) Legend Biotech Corp (LEGN) Biogen Inc (BIIB) Arcellx, Inc. (ACLX) Aardvark Therapeutics, Inc (AARD) One Cash (ONC) Insmed, Inc. (INSM) Terns Pharmaceuticals, Inc. (TERN) Cytokinetics Inc. (CYTK) Arcus Biosciences, Inc. (RCUS) Vaxcyte, Inc. (PCVX) Kymera Therapeutics, Inc. (KYMR) Alnylam Pharmaceuticals, Inc. (ALNY) Nanobiotix S.A. (NBTX) Sagimet Biosciences Inc. (SGMT) Genenta Science S.p.A. (GNTA) Prime Medicine, Inc. (PRME) IO Biotech, Inc. (IOBT) Lyell Immunopharma, Inc. (LYEL) Nurix Therapeutics, Inc. (NRIX) Rapport Therapeutics, Inc. (RAPP) Bausch & Lomb Corp (BLCO) Recursion Pharmaceuticals, Inc. (RXRX) Neurocrine Biosciences, Inc. (NBIX) Alumis Inc. (ALMS) Sana Biotechnology, Inc. (SANA) Vera Therapeutics, Inc. (VERA) ArriVent BioPharma, Inc. (AVBP) Oruka Therapeutics, Inc. Common Stock (ORKA) Jade Biosciences, Inc. (JBIO) IDEAYA Biosciences, Inc. Common Stock (IDYA) Ocular Therapeutix, Inc. (OCUL) Kyverna Therapeutics, Inc. (KYTX) Cullinan Management, Inc. (CGEM) Instil Bio, Inc. (TIL) Abivax SA (ABVX) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Xenon Pharmaceuticals Inc (XENE) Sarepta Therapeutics, Inc. (SRPT) LB Pharmaceuticals Inc. (LBRX) BEAM (BEAM) Beam Therapeutics, Inc. (BEAM) Soleno Therapeutics, Inc. Common Stock (SLNO) Annovis Bio Inc. (ANVS) Disc Medicine, Inc. Common Stock (IRON)
Top posts by engagements in the last [--] hours
": @Alnylam CEO Yvonne Greenstreet discusses the launch of Amvuttra in ATTR-CM and the company's new [----] ambitions. $ALNY Full video: https://www.biotechtv.com/post/alnylam-pharmaceuticals-january-13-2025 https://www.biotechtv.com/post/alnylam-pharmaceuticals-january-13-2025"
X Link 2026-01-13T23:42Z 10.7K followers, [----] engagements
": @Nanobiotix has a new platform that is meant to help RNA/DNA-based therapies gene therapies oncolytic viruses and other liver-delivered medicines have better efficacy. $NBTX Full video: https://www.biotechtv.com/post/nanobiotix-jefferies-london-november-18-2025 https://www.biotechtv.com/post/nanobiotix-jefferies-london-november-18-2025"
X Link 2025-11-18T19:36Z 10.7K followers, [----] engagements
": Later tonight from Boston we will be visiting @UpstreamBio to discuss today's asthma data. Let us know any questions you'd like asked. $UPB"
X Link 2026-02-11T15:32Z 10.7K followers, [----] engagements
": @sagimet presented a subset analysis of the FASCINATE-2 P2 trial of denifanstat suggesting improved fibrosis in MASH. #TLM24 $SGMT Full video: https://www.biotechtv.com/post/sagimet-biosciences-november-19-2024 https://www.biotechtv.com/post/sagimet-biosciences-november-19-2024"
X Link 2024-11-18T15:59Z 10.6K followers, [----] engagements
": Milan based @GenentaScience recently raised [--] million from a government investment fund as it takes its cell therapy into the clinic in renal cell carcinoma. $GNTA Full video: https://www.biotechtv.com/post/genenta-science-may-6-2025 https://www.biotechtv.com/post/genenta-science-may-6-2025"
X Link 2025-05-06T15:30Z 10.7K followers, [----] engagements
": @PrimeMedicine's new CEO Allan Reine walks us through the prime editing company's new focused pipeline. $PRME Full video: https://www.biotechtv.com/post/prime-medicine-july-17-2025 https://www.biotechtv.com/post/prime-medicine-july-17-2025"
X Link 2025-07-17T18:21Z 10.7K followers, 37.2K engagements
": @IOBiotech CEO Mai-Britt Zocca discusses the phase [--] pivotal trial result of the cancer vaccine Cylembio in first line advanced melanoma - and the company's strategy ahead. $IOBT Full video: https://www.biotechtv.com/post/io-biotech-august-15-2025 https://www.biotechtv.com/post/io-biotech-august-15-2025"
X Link 2025-08-15T16:17Z 10.7K followers, 13.2K engagements
": @MenloVentures published a report showing that the healthcare industry is the leading adopter of AI - @derekgxiao one of the co-authors shares key takeaways. Full video: https://www.biotechtv.com/post/menlo-ventures-ai-healthcare-derek-xiao https://www.biotechtv.com/post/menlo-ventures-ai-healthcare-derek-xiao"
X Link 2025-11-05T14:00Z 10.7K followers, [----] engagements
": @BeOneMedicines announced a phase [--] success for its HER2 bispecific today in gastric cancer. @johnvoyler walks us through that and the whole pipeline. $ONC Full video: https://www.biotechtv.com/post/beone-medicines-jefferies-london-november-17-2025 https://www.biotechtv.com/post/beone-medicines-jefferies-london-november-17-2025"
X Link 2025-11-17T17:11Z 10.7K followers, [----] engagements
": Lyell Immunopharma CEO Lynn Seely discusses her company's CD19/CD20 dual antigen CAR-T data at ASH. $LYEL Full video: https://www.biotechtv.com/post/lyell-immunopharma-ash-2025 https://www.biotechtv.com/post/lyell-immunopharma-ash-2025"
X Link 2025-12-08T00:19Z 10.7K followers, [----] engagements
": @Nurix_Tx CEO Arthur Sands discusses his company's BTK degrader data at ASH and highlights the benefits of degraders more broadly in oncology and I&I. $NRIX Full video: https://www.biotechtv.com/post/nurix-therapeutics-ash-2025 https://www.biotechtv.com/post/nurix-therapeutics-ash-2025"
X Link 2025-12-08T22:00Z 10.7K followers, [----] engagements
": Rapport Therapeutics has derived what it believes is 'unprecedented' early efficacy for its precision neuroscience treatment in focal onset seizures - its confidence comes from a unique trial design. $RAPP Full video: https://www.biotechtv.com/post/rapport-therapeutics-december-10-2025 https://www.biotechtv.com/post/rapport-therapeutics-december-10-2025"
X Link 2025-12-10T19:05Z 10.7K followers, [----] engagements
": @PolarisVC's Amy Schulman describes how her career in law led to running businesses for Pfizer and ultimately joining the VC world. She shares leanings from the last [--] years of biotech investing. Full video: https://www.biotechtv.com/post/bioventure-voices-polaris-partners-amy-schulman https://www.biotechtv.com/post/bioventure-voices-polaris-partners-amy-schulman"
X Link 2025-12-29T13:00Z 10.7K followers, [----] engagements
": Meeting spaces around Union Square are so expensive during JPM that one venture capital firm decided to host its meetings this week on a van roving around town. Say hello to THE HATTEBUS"
X Link 2026-01-12T01:21Z 10.6K followers, 97.9K engagements
": @BauschLomb Chairman & CEO @brentlsaunders covers the company's pharmaceutical pipeline for the eye. $BLCO Full video: https://www.biotechtv.com/post/bausch-lomb-janaury-12-2025 https://www.biotechtv.com/post/bausch-lomb-janaury-12-2025"
X Link 2026-01-13T02:22Z 10.7K followers, [----] engagements
": @Bridgebio Founder and CEO Neil Kumar shares his take on the state of biotech. $BBIO"
X Link 2026-01-14T00:55Z 10.7K followers, [----] engagements
": @argenxglobal recently announced that Karen Massey will become CEO as Tim Van Hauwermeiren transitions to Non-Executive Chairman in May. They both reflect on past success and the road ahead. $ARGX"
X Link 2026-01-14T02:33Z 10.7K followers, [----] engagements
": @BridgeBioPharma Founder & CEO Neil Kumar comments on the launch of Attruby and the company's next-generation efforts in this space. $BBIO"
X Link 2026-01-14T13:53Z 10.7K followers, [----] engagements
": @Insmed today has a $35B market cap but it wasn't always like that. CEO Will Lewis shares advice for entrepreneurs about making it through the ups and downs of biotech. $INSM"
X Link 2026-01-14T16:57Z 10.7K followers, [----] engagements
": @Insmed CEO Will Lewis discusses the launch BRINSUPRI and pipeline readouts ahead in [----]. $INSM. Full video: https://www.biotechtv.com/post/insmed-january-14-2026 https://www.biotechtv.com/post/insmed-january-14-2026"
X Link 2026-01-14T18:18Z 10.6K followers, [----] engagements
": @RecursionPharma's new CEO Najat Khan shares her vision for the company and for AI in biotech. $RXRX Full video: https://www.biotechtv.com/post/recursion-january-14-2026 https://www.biotechtv.com/post/recursion-january-14-2026"
X Link 2026-01-15T06:41Z 10.6K followers, [----] engagements
": @neurocrine's CEO Kyle Gano describes how the company's novel muscarinic agonist portfolio is rooted in novel drug design with its lead M4 agonist in late-stage trials. $NBIX Full video: https://www.biotechtv.com/post/neurocrine-biosciences-january-15-2026 https://www.biotechtv.com/post/neurocrine-biosciences-january-15-2026"
X Link 2026-01-15T15:41Z 10.7K followers, [----] engagements
": @_Alumis' CEO Martin Babler walks us through the two successful phase [--] trials the company announced for its TYK2 last week. $ALMS Full video: https://www.biotechtv.com/post/alumis-january-15-2026 https://www.biotechtv.com/post/alumis-january-15-2026"
X Link 2026-01-15T23:22Z 10.7K followers, [----] engagements
": Sana Bio's CEO Steve Harr describes the science behind the company's cell therapy program that aims to be a cure for type [--] diabetes. $SANA Full video: https://www.biotechtv.com/post/sana-biotechnology-january-15-2026 https://www.biotechtv.com/post/sana-biotechnology-january-15-2026"
X Link 2026-01-16T00:45Z 10.7K followers, 19.7K engagements
": This was a big week for the emerging protein degrader class of medicines with multiple companies presenting BTK data at ASH and Kymera announcing STAT6 data in atopic dermatitis. One of the leading CEOs in the field explains the promise"
X Link 2025-12-12T19:14Z 10.7K followers, [----] engagements
": @Official_VeraTx announced this week that the FDA accepted the companys filing for atacicept a potential new treatment for IgA Nephropathy. $VERA Full video: https://www.biotechtv.com/post/vera-therapeutics-january-11-2026 https://www.biotechtv.com/post/vera-therapeutics-january-11-2026"
X Link 2026-01-12T03:40Z 10.7K followers, [----] engagements
": Clear Street Senior Biotech Analyst Kaveri Pohlman shares her take on biotech for [----] and discusses her top picks. $AVBP $ORKA $JBIO $ZURA $PVLA Full video: https://www.biotechtv.com/post/kaveri-pohlman-january-22-2026 https://www.biotechtv.com/post/kaveri-pohlman-january-22-2026"
X Link 2026-01-22T16:33Z 10.7K followers, [----] engagements
": Tune in to BiotechTV as @MassBio President & CEO @KendalleOC hosts a discussion with Leslie Williams and Ed Kaye about leadership and the biotech ecosystem"
X Link 2026-02-12T17:34Z 10.7K followers, [----] engagements
": "A special drug like this does not come around every day." @TernsPharma CEO Amy Burroughs previews the company's upcoming ASH presentation for tern-701 in relapsed/refractory cml. $TERN Full video: https://www.biotechtv.com/post/terns-pharmaceuticals-november-19-2025 https://www.biotechtv.com/post/terns-pharmaceuticals-november-19-2025"
X Link 2025-11-19T18:19Z 10.7K followers, [----] engagements
": @NYSE Market Strategist @Eric_Criscuolo discusses how the newly appointed Federal Reserve Chair and other market factors might affect the biotech sector. Full video: https://www.biotechtv.com/post/nyse-eric-criscuolo-february-2-2026 https://www.biotechtv.com/post/nyse-eric-criscuolo-february-2-2026"
X Link 2026-02-02T22:42Z 10.7K followers, [----] engagements
": @generalatlantic's Brett Zbar describes investing through the lens of private equity and touches on key technology themes that interest him. Full video: https://www.biotechtv.com/post/bioventure-voices-brett-zbar-february-9-2026 https://www.biotechtv.com/post/bioventure-voices-brett-zbar-february-9-2026"
X Link 2026-02-09T12:30Z 10.7K followers, 13K engagements
": @UpstreamBio's CEO Rand Sutherland discusses today's severe asthma data for verekitug a TSLP receptor antagonist. $UPB Full video: https://www.biotechtv.com/post/upstream-bio-february-11-2026 https://www.biotechtv.com/post/upstream-bio-february-11-2026"
X Link 2026-02-11T23:38Z 10.7K followers, [----] engagements
": Mizuho Senior Biotech Analyst @soowannaway shares his take on three key biotech trials that are scheduled to read out soon and one that recently happened. $IDYA $EYPT $OCUL $PVLA $CRVS Full video: https://www.biotechtv.com/post/graig-suvannavejh-february-12-2026 https://www.biotechtv.com/post/graig-suvannavejh-february-12-2026"
X Link 2026-02-12T23:38Z 10.7K followers, 23.2K engagements
": Checking in on the progress of CAR-T for autoimmune conditions with the CEO of @Kyverna_Tx - the company's first (and first for the field) registration intended trial will read in the first half of [----]. $KYTX Full video: https://www.biotechtv.com/post/kyverna-therapeutics-august-13-2025 https://www.biotechtv.com/post/kyverna-therapeutics-august-13-2025"
X Link 2025-08-13T23:55Z 10.7K followers, [----] engagements
": @CullinanTx's CEO Nadim Ahmed highlights the company's FLT3xCD3 bispecific T-cell engager data at ASH in AML and MDS. $CGEM Full video: https://www.biotechtv.com/post/cullinan-therapeutics-ash-2025 https://www.biotechtv.com/post/cullinan-therapeutics-ash-2025"
X Link 2025-12-08T19:55Z 10.7K followers, [----] engagements
": Aaron Morris CEO of @PostEra_AI discusses the companys collaborations with Pfizer and Amgen and how AI can improve drug development in womens health"
X Link 2026-01-14T06:10Z 10.7K followers, [----] engagements
": @astellas' CEO Naoki Okamura describes the type of assets the company looks for externally and covers key internal pipeline assets. Full video: https://www.biotechtv.com/post/astellas-pharma-january-14-2026 https://www.biotechtv.com/post/astellas-pharma-january-14-2026"
X Link 2026-01-15T02:26Z 10.7K followers, [----] engagements
": Perceptive Advisors' Joe Edelman one of the top investors in biotech shares his investment philosophy. See the whole interview here: https://www.biotechtv.com/post/joseph-edelman-perceptive-advisors-january-15-2026 https://www.biotechtv.com/post/joseph-edelman-perceptive-advisors-january-15-2026"
X Link 2026-01-17T18:45Z 10.7K followers, 16.4K engagements
": @InstilBio CEO Bronson Crouch discusses the company's PD1 x VEGF and shares a quick take on this morning's competitor news. #ASCO25 $TIL Full video: https://www.biotechtv.com/post/instil-bio-asco-2025 https://www.biotechtv.com/post/instil-bio-asco-2025"
X Link 2025-05-30T21:10Z 10.7K followers, [----] engagements
"- : @Abivax_ CEO Marc de Garidel discusses physician and payor feedback after obefazimod's phase [--] UC induction readouts and next steps regarding maintenance and Crohn's. #BIOEurope $ABVX Full video: https://www.biotechtv.com/post/bio-europe-2025-abivax https://www.biotechtv.com/post/bio-europe-2025-abivax"
X Link 2025-11-03T10:23Z 10.7K followers, 51.6K engagements
": Legend Biotech CEO Ying Huang shares a post-earnings update from the company's new R&D Center in Philadelphia. $LEGN Full video: https://www.biotechtv.com/post/legend-biotech-november-13-2025 https://www.biotechtv.com/post/legend-biotech-november-13-2025"
X Link 2025-11-13T21:18Z 10.7K followers, [----] engagements
": During an event at Legend Biotech's new R&D Center in Philadelphia today a CAR-T recipient had some words for the biotech industry"
X Link 2025-11-13T22:48Z 10.7K followers, [----] engagements
": @LegendBiotech CEO Ying Huang discusses new long-term Carvykti data looming competition a CD19+CD20 program and in vivo CAR-T. $LEGN Full video: https://www.biotechtv.com/post/legend-biotech-ash-2025 https://www.biotechtv.com/post/legend-biotech-ash-2025"
X Link 2025-12-06T19:44Z 10.7K followers, [----] engagements
": We will check in with Mizuho senior analyst Salim Syed on some of the key names he covers. $BBIO $CYTK $PCVX $BIIB $RCUS and more"
X Link 2026-01-07T12:08Z 10.7K followers, [----] engagements
": @Mizuho Senior Biotech Analyst Salim Syed highlights key companies in the news he covers heading into the new year. $BBIO $CYTK $PCVX $BIIB $RCUS Full video: https://www.biotechtv.com/post/mizuho-salim-syed-january-7-2026 https://www.biotechtv.com/post/mizuho-salim-syed-january-7-2026"
X Link 2026-01-07T17:50Z 10.7K followers, 12.1K engagements
": Baird Senior Analyst @BrianSkorney comments on Monday's conference news and highlights his top picks ahead for [----]. $BHVN $XENE $BIIB $SRPT Full video: https://www.biotechtv.com/post/brian-skorney-january-12-2025 https://www.biotechtv.com/post/brian-skorney-january-12-2025"
X Link 2026-01-12T17:15Z 10.7K followers, [----] engagements
": CEO Heather Turner tells us about the neuropsychiatric diseases medicine that enabled @lb_pharma to IPO in a tough market last year. $LBRX Full video: https://www.biotechtv.com/post/lb-pharmaceuticals-january-15-2026 https://www.biotechtv.com/post/lb-pharmaceuticals-january-15-2026"
X Link 2026-01-15T21:59Z 10.7K followers, [----] engagements
": @arcellx CEO Rami Elghandour discusses the results presented today of the iMMagine-1 Study for the company's BCMA CAR-T. #EHA2025 $ACLX Full video: https://www.biotechtv.com/post/arcellx-eha-2025 https://www.biotechtv.com/post/arcellx-eha-2025"
X Link 2025-06-14T19:48Z 10.7K followers, [----] engagements
": @UpstreamBio is focused on the TSLP space and has a unique approach of targeting the receptor as opposed to the ligand. It might give them a better dosing and efficacy profile. $UPB @Stifel @StifelInst Full video: https://www.biotechtv.com/post/upstream-bio-stifel-november-11-2025 https://www.biotechtv.com/post/upstream-bio-stifel-november-11-2025"
X Link 2025-11-11T15:09Z 10.7K followers, [----] engagements
": @KymeraTx's Founder & CEO @NelloMainolfi recaps Monday's STAT6 data and discusses the next steps in development. $KYMR Full video: https://www.biotechtv.com/post/kymera-therapeutics-december-10-2025 https://www.biotechtv.com/post/kymera-therapeutics-december-10-2025"
X Link 2025-12-10T23:35Z 10.7K followers, [----] engagements
": @BeamTx's CEO @john_evans3 shares an update on based editing for alpha-1 antitrypsin deficiency sickle cell disease and more. $BEAM Full video: https://www.biotechtv.com/post/beam-therapeutics-january-12-2026 https://www.biotechtv.com/post/beam-therapeutics-january-12-2026"
X Link 2026-01-12T21:57Z 10.7K followers, [----] engagements
": @SolenoTx Chairman & CEO Anish Bhatnager discusses the launch of its Prader-Willi syndrome therapy VYKAT XR. $SLNO Full video: https://www.biotechtv.com/post/soleno-therapeutics-january-14-2026 https://www.biotechtv.com/post/soleno-therapeutics-january-14-2026"
X Link 2026-01-14T22:03Z 10.7K followers, [----] engagements
": Co-Founders Sheila Gujrathi and Julia Owens talk about the creation of the Biotech CEO Sisterhood and the new dimensions and next steps it is taking as an organization ahead. Full video: https://www.biotechtv.com/post/biotech-ceo-sisterhood-panel-jpm26 https://www.biotechtv.com/post/biotech-ceo-sisterhood-panel-jpm26"
X Link 2026-02-02T13:21Z 10.7K followers, [----] engagements
": Today we are in New York at the home of our sponsor the @NYSE for its annual partnership day. If you are a biotech company looking to list this year (or beyond) please reach out to Johanna Grossman"
X Link 2026-02-02T20:42Z 10.7K followers, [----] engagements
": @OvidRx's new CEO Meg Alexander walks us through the company's lead programs in neurology. $OVID Full video: https://www.biotechtv.com/post/ovid-therapeutics-february2-2025 https://www.biotechtv.com/post/ovid-therapeutics-february2-2025"
X Link 2026-02-02T21:57Z 10.7K followers, [----] engagements
": @mammothbiosci Co-Founder & CEO @martintrevor_ shares advice for scientists thinking about building a biotech company"
X Link 2026-02-02T22:55Z 10.7K followers, [----] engagements
": @AnnovisBio's Founder & CEO Maria Maccecchini shares an update on the oral small molecule buntanetap which is currently in a pivotal trial for Alzheimer's. $ANVS Full video: https://www.biotechtv.com/post/annovis-bio-february-2-2026 https://www.biotechtv.com/post/annovis-bio-february-2-2026"
X Link 2026-02-02T23:59Z 10.7K followers, [----] engagements
": @mammothbioscis Co-Founder & CEO @martintrevor_ talks about the learning curve he experienced when making the jump from academia to industry"
X Link 2026-02-03T20:43Z 10.7K followers, [----] engagements
": In recent years biotech has seen a surge of success in the neuroscience field. @OvidRx's CEO Meg Alexander describes what she believes is behind it"
X Link 2026-02-03T21:34Z 10.7K followers, [----] engagements
": @mammothbioscis Co-Founder & CEO @martintrevor_ describes how the company looks beyond Cas9 as it uses CRISPR to develop new therapies"
X Link 2026-02-04T17:36Z 10.7K followers, [----] engagements
": @GatcHealth has created an AI platform to predict clinical trial outcomes - it is already being used for things from insuring clinical trials to helping with pipeline optimization Full video: https://www.biotechtv.com/post/gatc-health-february-4-2026 https://www.biotechtv.com/post/gatc-health-february-4-2026"
X Link 2026-02-04T22:31Z 10.7K followers, [----] engagements
": Could the time of day that cancer immunotherapy treatments are administered affect their effectiveness An intriguing @NatureMedicine paper suggests that the answer could be yes. Link to research: https://www.nature.com/articles/s41591-025-04181-w https://www.nature.com/articles/s41591-025-04181-w"
X Link 2026-02-09T19:25Z 10.7K followers, [----] engagements
": With #SLAS2026 in Boston right now the use of machine learning with robotics and automated lab equipment is on full display. One company in the space @AtinaryTech showed us their "Self-Driving Lab" setup in the Seaport. Full video: https://www.biotechtv.com/post/atinary-self-driving-lab-slas-2026 https://www.biotechtv.com/post/atinary-self-driving-lab-slas-2026"
X Link 2026-02-10T19:20Z 10.7K followers, [----] engagements
": "We are able to generate as many data an knowledge in a week as what a student can produce throughout their PhD." @AtinaryTech's CTO Loc Roch describes how a combination of machine learning and robotics is changing how science is done"
X Link 2026-02-10T20:06Z 10.7K followers, [----] engagements
": Mizuho Senior Biotech Analyst @soowannaway gave his take on the recent $CRVS ITK data today. Plus discussing three other trials scheduled to read out imminently. See the full episode: https://www.biotechtv.com/post/graig-suvannavejh-february-12-2026 https://www.biotechtv.com/post/graig-suvannavejh-february-12-2026"
X Link 2026-02-13T01:05Z 10.7K followers, [----] engagements
": @MassBio CEO @KendalleOC moderates a discussion with @AuroraTher CEO Ed Kaye and DaCapo Brainscience CEO @LeslieJWilliams about the future of biotech. Watch the full discussion: https://www.biotechtv.com/post/ceo-roundtable-kendalle-burlin-oconnell-ed-kaye-leslie-williams-february-13 https://www.biotechtv.com/post/ceo-roundtable-kendalle-burlin-oconnell-ed-kaye-leslie-williams-february-13"
X Link 2026-02-13T13:00Z 10.7K followers, [----] engagements
": @BeOneMedicines CEO @johnvoyler on the state of biotech modalities and SF vs London. $ONC"
X Link 2025-11-17T17:47Z 10.6K followers, [----] engagements
": Ipsen has done a string of deals over recent years including acquiring ImCheck last month. CEO David Loew says the company has billions in firepower to do more. Full video: https://www.biotechtv.com/post/ipsen-jefferies-london-november-19-2025 https://www.biotechtv.com/post/ipsen-jefferies-london-november-19-2025"
X Link 2025-11-19T19:46Z 10.6K followers, [----] engagements
": @DiscMedicine CEO John Quisel walks us through the RALLY-MF Phase [--] trial data of DISC-0974 in anemia of myelofibrosis. $IRON Full video: https://www.biotechtv.com/post/disc-medicine-ash-2025 https://www.biotechtv.com/post/disc-medicine-ash-2025"
X Link 2025-12-07T17:35Z 10.6K followers, [----] engagements
": @BluejayThera's CEO Keting Chu talks about what led to the the successful $620M+ acquisition of her company and its chronic hepatitis delta virus antibody by @mirumpharma. Full video: https://www.biotechtv.com/post/bluejay-therapeutics-january-14-2026 https://www.biotechtv.com/post/bluejay-therapeutics-january-14-2026"
X Link 2026-01-17T22:22Z 10.6K followers, [----] engagements
": @Nicole_Paulk describes how @SirenBio is using AAV gene therapy to treat cancer. Plus platform companies vs asset companies in biotech"
X Link 2026-01-26T22:57Z 10.7K followers, [----] engagements
": Corvus Pharma CEO Richard Miller fields follow-up questions about last week's atopic dermatitis data for the ITK inhibitor soquelitinib. $CRVS Full video: https://www.biotechtv.com/post/corvus-pharma-january-28-2026 https://www.biotechtv.com/post/corvus-pharma-january-28-2026"
X Link 2026-01-28T20:36Z 10.6K followers, 24.3K engagements
": Lexeo Therapeutics' CEO Nolan Townsend highlights recent FA cardiomyopathy data and the path ahead in that indication. Plus the latest on PKP2 ACM and more. $LXEO Full video: https://www.biotechtv.com/post/lexeo-therapeutics-april-23-2025 https://www.biotechtv.com/post/lexeo-therapeutics-april-23-2025"
X Link 2025-04-23T22:09Z 10.7K followers, 19.8K engagements
": @MazeInBiotech which had its IPO earlier this year is using insights from genetics to develop small molecules - its most advanced program is for a genetic kidney disease. $MAZE Full video: https://www.biotechtv.com/post/maze-therapeutics-august-11-2025 https://www.biotechtv.com/post/maze-therapeutics-august-11-2025"
X Link 2025-08-11T21:36Z 10.7K followers, [----] engagements
"Company News: @LongboardP's CEO describes today's open label extension data for bexicaserin in Developmental and Epileptic Encephalopathies. $LBPH Full video: https://www.biotechtv.com/post/longboard-pharmaceuticals-june-10-2024 https://www.biotechtv.com/post/longboard-pharmaceuticals-june-10-2024"
X Link 2024-06-10T22:38Z 10.7K followers, 11K engagements
": @KitePharma's global head discusses the progress of the CAR-T field @arcellx's BCMA data cures in CD19 autoimmune and future targets. #ASH24 $GILD $ACLX Full video: https://www.biotechtv.com/post/kite-pharma-ash-2024 https://www.biotechtv.com/post/kite-pharma-ash-2024"
X Link 2024-12-09T05:44Z 10.7K followers, [----] engagements
": Rachel Haurwitz shares an update on @CaribouBio's allo CAR-T programs in NHL multiple myeloma and lupus. $CRBU Full video: https://www.biotechtv.com/post/caribou-biosciences-january-15-2025 https://www.biotechtv.com/post/caribou-biosciences-january-15-2025"
X Link 2025-01-15T22:05Z 10.7K followers, [----] engagements
": @KymeraTx Founder & CEO @NelloMainolfi discusses the safety degradation and biomarker profile he sees in the company's STAT6 healthy volunteer data. $KYMR Full video: https://www.biotechtv.com/post/kymera-therapeutics-june-4-2025 https://www.biotechtv.com/post/kymera-therapeutics-june-4-2025"
X Link 2025-06-04T21:11Z 10.7K followers, 10K engagements
": Checking in with the co-founders of @AmylyxPharma which now has one program in pivotal another that may start soon and earlier stage clinical programs that will have data this year. $AMLX Full video: https://www.biotechtv.com/post/amylyx-pharmaceuticals-june-25-2025 https://www.biotechtv.com/post/amylyx-pharmaceuticals-june-25-2025"
X Link 2025-06-25T22:12Z 10.7K followers, [----] engagements
": The CEO of @AltoNeuro which is working on precision medicine and enhanced patient selection for neuroscience talks about how the company is using AI and machine learning in its development programs. Full video: https://www.biotechtv.com/post/alto-neuroscience-july-22-2025 https://www.biotechtv.com/post/alto-neuroscience-july-22-2025"
X Link 2025-07-23T02:39Z 10.7K followers, [----] engagements
": Dropping by the @BeOneMedicines booth at ASH and visiting with @johnvoyler. Plus what does a CEO do at a conference like this"
X Link 2025-12-06T21:39Z 10.7K followers, [----] engagements
"From Zurich: The Co-Founder & CEO of @MolecularPrtnrs describes their DARPin technology platform and how it is being put to use. $MOLN Full video: https://twitter.com/i/web/status/1838399067430207974 https://www.biotechtv.com/post/molecular-partners-september-24-2024 https://twitter.com/i/web/status/1838399067430207974 https://www.biotechtv.com/post/molecular-partners-september-24-2024"
X Link 2024-09-24T02:04Z 10.7K followers, [----] engagements
": @AstriaTx licensed its HAE treatment Navenibart to Kaken Pharmaceutical for the Japanese market. It is a kallikrein inhibitor that is in phase [--] and is dosed up to every six months. $ATXS Full video: https://www.biotechtv.com/post/astria-therapeutics-august-7-2025 https://www.biotechtv.com/post/astria-therapeutics-august-7-2025"
X Link 2025-08-07T19:25Z 10.7K followers, [----] engagements
": Zealand Pharma CEO Adam Steensberg (strongly) believes that amylins will overtake GLPs as the backbones of obesity treatments in the future. Full video: https://www.biotechtv.com/post/zealand-pharma-jefferies-london-november-18-2025 https://www.biotechtv.com/post/zealand-pharma-jefferies-london-november-18-2025"
X Link 2025-11-18T20:29Z 10.7K followers, 11.8K engagements
"Company News: Spun out of Paragon Oruka Therapeutics raised $275M in a reverse merger today to tackle skin conditions in the I&I space. The company's CEO describes the science behind it. Full video: https://twitter.com/i/web/status/1775634322672017440 https://www.biotechtv.com/post/oruka-therapeutics-april-3-2024 https://twitter.com/i/web/status/1775634322672017440 https://www.biotechtv.com/post/oruka-therapeutics-april-3-2024"
X Link 2024-04-03T21:19Z 10.7K followers, [----] engagements
"Company News: The CEO of @Context_Tx on raising $100M for a Claudin [--] x CD3 bispecific this month. $CNTX Full video: https://www.biotechtv.com/post/context-therapeutics-may-21-2024 https://www.biotechtv.com/post/context-therapeutics-may-21-2024"
X Link 2024-05-21T10:41Z 10.7K followers, [----] engagements
"From Research Triangle NC: With key EHA data coming up Shattuck looks to build on its hypothesis that adding an immune agonism component will transform the SIRP space. $STTK Full video: https://twitter.com/i/web/status/1793961396515868871 https://www.biotechtv.com/post/shattuck-labs-may-24-2024 https://twitter.com/i/web/status/1793961396515868871 https://www.biotechtv.com/post/shattuck-labs-may-24-2024"
X Link 2024-05-24T11:05Z 10.7K followers, [----] engagements
"Company News: Aardvark Therapeutics CEO Tien Lee on this month's $85M series C and leveraging TAS2R to modulate hunger and as a weight loss strategy. Full video: https://twitter.com/i/web/status/1795550451489702105 https://www.biotechtv.com/post/aardvark-therapeutics-may-28-2024 https://twitter.com/i/web/status/1795550451489702105 https://www.biotechtv.com/post/aardvark-therapeutics-may-28-2024"
X Link 2024-05-28T20:19Z 10.7K followers, [----] engagements
"Behind the Science: Philadelphia-based @Passage_Bio is aiming to treat frontotemporal dementia by using an AAV gene therapy to boost progranulin levels in the brain. Full video: https://www.biotechtv.com/post/passage-bio-july-10-2024 https://www.biotechtv.com/post/passage-bio-july-10-2024"
X Link 2024-07-10T19:10Z 10.7K followers, [----] engagements
"Company News: Praxis Precision Medicines a CNS focused company has key data events scheduled to read out over the remainder of the year. CEO Marcio Souza describes the programs. Full video: https://www.biotechtv.com/post/praxis-precision-medicines-august-14-2024 https://www.biotechtv.com/post/praxis-precision-medicines-august-14-2024"
X Link 2024-08-15T00:20Z 10.7K followers, [----] engagements
"Company News: The CEO of @TarsusRx shares an update on the launch of XDEMVY and what the company is doing to reach more patients in the quarters ahead. $TARS Full video: https://www.biotechtv.com/post/tarsus-pharmaceuticals-september-3-2024 https://www.biotechtv.com/post/tarsus-pharmaceuticals-september-3-2024"
X Link 2024-09-03T17:41Z 10.7K followers, [----] engagements
": Many companies are trying to differentiate themselves in the obesity drug race by developing an oral GLP-1. But count Zealand Pharma's CEO skeptical of this approach. See our full deep dive on the obesity space with him here: https://www.biotechtv.com/post/zealand-pharma-october-10-2024 https://www.biotechtv.com/post/zealand-pharma-october-10-2024"
X Link 2024-10-11T12:28Z 10.7K followers, [----] engagements
"' : Dr. Tien Lee Founder and CEO of Aardvark Therapeutics spoke with @nyse's @JudyKShaw about developing therapies that target bitter taste receptors to turn off hunger"
X Link 2024-10-31T18:15Z 10.7K followers, [----] engagements
": After announcing FIH data from its oral GLP in obesity in September @TernsPharma is also getting ready to release initial data in December for its allosteric BCR ABL cancer program. $TERN Full video: https://www.biotechtv.com/post/terns-pharmaceuticals-november-21-2024 https://www.biotechtv.com/post/terns-pharmaceuticals-november-21-2024"
X Link 2024-11-21T09:05Z 10.7K followers, [----] engagements
": @Vir_Biotech presented data from programs for chronic hepatitis B and chronic hepatitis delta at #TLM24. $VIR Full video: https://www.biotechtv.com/post/vir-biotechnology-november-22-2024 https://www.biotechtv.com/post/vir-biotechnology-november-22-2024"
X Link 2024-11-21T20:13Z 10.7K followers, [----] engagements
": @LegendBiotech's CEO Ying Huang discusses new CARVYKTI data at #ASCO25 as well as early stage data for emerging CAR-T targets against solid tumors. $LEGN Full video: https://www.biotechtv.com/post/legend-biotech-asco-2025 https://www.biotechtv.com/post/legend-biotech-asco-2025"
X Link 2025-06-02T00:23Z 10.7K followers, [----] engagements
": @BicaraTx's CEO Claire Mazumdar discusses the company's EGFR x TGF- data in head and neck cancer and compares and contrasts it with a closely watched competitor. #ASCO25 $BCAX Full video: https://www.biotechtv.com/post/bicara-therapeutics-asco-2025 https://www.biotechtv.com/post/bicara-therapeutics-asco-2025"
X Link 2025-06-02T01:22Z 10.7K followers, 19.9K engagements
": @CandelTx's CEO @paulpetertak describes phase [--] prostate cancer data from the company's off-the-shelf adeno delivered cancer immunotherapy. #ASCO25 $CADL Full video: https://www.biotechtv.com/post/candel-therapeutics-asco-2025 https://www.biotechtv.com/post/candel-therapeutics-asco-2025"
X Link 2025-06-02T23:55Z 10.7K followers, [----] engagements
": Ahead of a year of increased clinical activity @entradatx's CEO Dipal Doshi discusses the company's EEV platform DMD programs and a Vertex partnership in DM1. Full video: https://www.biotechtv.com/post/entrada-therapeutics-october-22-2025 https://www.biotechtv.com/post/entrada-therapeutics-october-22-2025"
X Link 2025-10-22T22:47Z 10.7K followers, [----] engagements
": Aardvark Therapeutics' approach to obesity is to inhibit hunger (vs appetite). It has a key pivotal trial reading in Prader-Willi syndrome next year and is also working on weight loss. $AARD @Stifel @StifelInst Full video: https://www.biotechtv.com/post/aardvark-therapeutics-stifel-november-11-2025 https://www.biotechtv.com/post/aardvark-therapeutics-stifel-november-11-2025"
X Link 2025-11-11T18:12Z 10.7K followers, [----] engagements
": BiotechTV attended the ribbon cutting ceremony of Legend Biotechs new R&D center in Philadelphia today which is in the new [----] Market life sciences building that was built by our sponsor @bt_prop. We caught up with Legend CEO Ying Huang there"
X Link 2025-11-13T20:22Z 10.7K followers, [----] engagements
": @AscentagePharma Chairman & CEO Dajun Yang shares an update on the company's Bcl-2 lisaftoclax which was recently approved in China and is in multiple global registration studies. $AAPG Full video: https://www.biotechtv.com/post/ascentage-pharma-ash-2025 https://www.biotechtv.com/post/ascentage-pharma-ash-2025"
X Link 2025-12-09T14:00Z 10.7K followers, [----] engagements
": Starting Sunday tune in to BiotechTV's coverage of biotech's biggest week of the year"
X Link 2026-01-09T19:19Z 10.7K followers, [----] engagements
": @arcellx CEO Rami Elghandour discusses a data update of the iMMagine-1 Study for the company's BCMA CAR-T. The data showed a 62% CR/sCR at a median follow-up of [---] months. #ASH24 $ACLX Full video: https://www.biotechtv.com/post/arcellx-ash-2024 https://www.biotechtv.com/post/arcellx-ash-2024"
X Link 2024-12-09T04:43Z 10.7K followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/creator/twitter::BiotechTV